189.05
+7.48
+(4.12%)
As of April 8 at 6:49:06 PM GMT+1. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 6 | 6 |
Avg. Estimate | 16.36B | 16.69B | 68.84B | 73.85B |
Low Estimate | 16.24B | 16.44B | 66.59B | 71.46B |
High Estimate | 16.48B | 16.94B | 70.33B | 76.15B |
Year Ago Sales | 15.26B | 15.71B | 64.11B | 68.84B |
Sales Growth (year/est) | 7.23% | 6.21% | 7.38% | 7.27% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
0HCZ.L | -- | -- | -- | -- |
S&P 500 | 6.55% | 6.50% | 9.70% | 14.29% |
Upgrades & Downgrades
Maintains | JP Morgan: Overweight to Overweight | 4/8/2025 |
Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 2/11/2025 |
Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 1/14/2025 |
Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 1/10/2025 |
Maintains | Barclays: Underweight to Underweight | 1/6/2025 |
Maintains | Piper Sandler: Overweight to Overweight | 11/26/2024 |